期刊文献+

基因芯片研究隐丹参酮对胰岛素抵抗卵巢颗粒细胞基因表达的影响 被引量:13

Studies on the Effect of Cryptotanshinone on Insulin Resistant Ovarial Granular Cells by DNA Microarray
暂未订购
导出
摘要 应用基因芯片技术,从基因水平分析隐丹参酮对胰岛素抵抗卵巢颗粒细胞基因表达的影响。采用猪卵巢颗粒细胞作为体外研究对象,利用磷酯酰肌醇-3激酶(PI-3K)特异性抑制剂——沃曼青霉素人工诱导猪卵巢胰岛素抵抗的细胞模型,以0.02g/L隐丹参酮进行干预,继续培养48h后,以Trizol法提取总RNA,采用猪全基因表达谱芯片技术筛选出差异表达基因。隐丹参酮组与沃曼处理组相比,共筛查出42个差异基因,其中22个基因表达下调,20个基因表达上调。研究表明,隐丹参酮可以通过调节多个基因、作用多个信号途径来改善胰岛素抵抗卵巢颗粒细胞的状态。 The mechanism of Cryptotanshinone in treating ovary insulin resistance is identified in this paper. The ovarian granulose cells from porcine follicles were isolated and cuhured in vitro, and insulin resistance was induced by treatment with Wortmannin. The cells were divided into 4 groups, the blank control group cultured with DMSO, the Wortmannin group cultured with Wortmannin 250 nmol/L, the Cryptotanshinone group cultured with Wotrmannin 250 nmoYL as well as 0.02 g/L Cryptotanshinone. After being incubated for 48 h, the total RNA was isolated from cells, and the differently expressed genes were screened from them by the gene chip technique. Then they were analyzed by molecule annotation system to get differential gene expression profiles and pathways of the four groups. The results show that 42 differential genes are screened through the channel gene chip technique, including 22 down- regulation genes and 20 up-regulation genes. These differential expression genes have various biological functions, such as lipid metabolism, intercellular signal transmission and so on. And the Cryptotanshinone may improve ovary insulin resistance by adjusting many genes and signal pathway. It is implied that Cryptotanshinone may be used to treat endocrine disease and reproductive barrier of polycystic ovary syndrome.
出处 《科技导报》 CAS CSCD 北大核心 2009年第15期39-43,共5页 Science & Technology Review
基金 黑龙江省自然科学基金重点项目(ZJY0606-01)
关键词 基因芯片 隐丹参酮 胰岛素抵抗 卵巢颗粒细胞 DNA microarray Cryptotanshinone insulin resistance ovarian granulosa cells
  • 相关文献

参考文献13

  • 1Schuring A N, Schulte N, Sonntag B, et al. Androgens and insulin-two key players in polycystic ovary syndrome [J]. Gynakol Geburtshilfliche Rundsch, 2008, 48: 9-15.
  • 2Montagnani M, Golovchenko I, et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic[J]. The Jourual of Biological Chemistry, 2002, 1(18): 1794-1799.
  • 3Zhang X, Feng J, Heng Y, et al. Characterization of differentially expressed gene sinovarian cancer by DNA icroarrays [J]. Int J Gynecol Cancer, 2005, 15(1): 50-57.
  • 4宋娟娟,丛晶,吴效科,侯丽辉.卵巢自身胰岛素抵抗放大其颗粒细胞增殖功能[J].科技导报,2008,26(6):58-62. 被引量:12
  • 5侯丽辉,王晓冰,吴效科.从“痰壅胞宫”病机理论论多囊卵巢综合征排卵障碍[J].中国中医基础医学杂志,2008,14(10):725-726. 被引量:89
  • 6郭红辉,凌文华.C-Jun氨基端激酶与胰岛素抵抗[J].中国医药生物技术,2007,2(5):391-393. 被引量:1
  • 7van Dam E W, Roellsema F, Helmerhorst F H, et al. Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2002, 87 (9): 4225-4230.
  • 8Amin A F, Abd E1 Aal D M, Darwish A M, et al. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome[J]. Fertil Steril, 2003, 79(4): 938-941.
  • 9程春霞,薛敏.多囊卵巢综合征与卵泡抑素关系的初步研究[J].中国现代医学杂志,2004,14(24):67-69. 被引量:2
  • 10Calvo R M, Villuendas G, Sancho J, et al. Role of the follistatin gene in women with polycystic ovary syndrome [J]. Fertil Steril, 2001, 75 (5): 1020-1023.

二级参考文献97

  • 1陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1998.1765-1767.
  • 2曹泽毅.中华妇产科学(第1版)[M].北京:人民卫生出版社,1999.35-37.
  • 3Shearer B G, Hoekstra W J. Recent advances in peroxisome proliferator-activated receptor scince [J]. Curr Med Chem,2003,10(4):267-280.
  • 4van Dijk G, de Vries K, Benthem L, et al. Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity[J].Eur J Pharmacol,2003,480(1-3):31-42.
  • 5Takeuchi T, Tsutsumi O. Basal leptin concentrations in women with normal and dysfunctional ovarian conditions [J]. Int J Gynaecol Obstet ,2000,69(2):127.
  • 6Amato G, Conte M, Mazziotti G, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles[J]. Obstet Gynecol,2003,101:1177-1182.
  • 7Ruan H, Pownall H J, Lodish H F. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB[J]. J Biol Chem, 2003,278(30):28181-28192.
  • 8Combs T P, Wagner J A, Benger J, et al. Induction of adipocyte complement related protein of 30 insulin sensitization [J]. Endocrinology,2002,143(3) :998.
  • 9Lindsay R S, Funahashi T, Hanson R L, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population[J]. Lancet, 2002,360 (9326): 57.
  • 10Maeda N, Takahashi M, Funahashi T, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, a adipose-derived protein [J]. Diabetes, 2001,50:2094-2099.

共引文献107

同被引文献129

引证文献13

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部